A Pilot Study of a Palliative Care Service Embedded in a Hepatology Clinic at a Large Public Hospital.

End-stage liver disease (ESLD) patients carry heavy symptom burdens and risk receiving aggressive and sometimes unwanted care at end of life. Palliative care (PC), which aims to alleviate symptoms and facilitate goal-concordant care in serious illness, may offer substantial benefits for ESLD patients but is not widely provided. To assess the impact of PC integrated within hepatology (PCIH) services on health care utilization, advance care planning (ACP), and hospice enrollment. We compared patients who received PCIH ( = 55) to a retrospective cohort ( = 57) receiving usual care in an outpatient hepatology clinic. From June 2016 to November 2017, we enrolled patients receiving care in a U.S. public hospital clinic who met the following inclusion criteria: (1) ESLD with a Model for End-Stage Liver Disease score ≥20, (2) hepatology approval for PC referral, and (3) at least one advanced complication of ESLD. We assessed patient demographics, clinical information, health care insurance status, health care utilization, completion of psychosocial assessments, and ACP using two-sided Fisher's exact test and Mann-Whitney U tests. Patients receiving PCIH more frequently had goals of care discussions (87.3% vs. 21.2%  ≤ 0.01), completed ACP documentation (56.4% vs. 7.0%,  ≤ 0.01), psychosocial assessments (98.2% vs. 35.1%,  ≤ 0.01), and hospice enrollment (25.5% vs. 7.0%,  = 0.01). Patients receiving PCIH who were hospitalized also had fewer mean hospitalization days (13 vs. 19.7 days,  ≤ 0.01). Embedding PC services in a hepatology clinic is a promising strategy to improve care for ESLD patients in public hospitals.